Generation of induced pluripotent stem cells from primary chronic myelogenous leukemia patient samples
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Generation of induced pluripotent stem cells from primary chronic myelogenous leukemia patient samples
Authors
Keywords
-
Journal
BLOOD
Volume 119, Issue 26, Pages 6234-6242
Publisher
American Society of Hematology
Online
2012-05-18
DOI
10.1182/blood-2011-07-367441
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival
- (2011) A. Hamilton et al. BLOOD
- Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells
- (2011) K. Hu et al. BLOOD
- Tissue-specific demethylation in CpG-poor promoters during cellular differentiation
- (2011) Genta Nagae et al. HUMAN MOLECULAR GENETICS
- DNA Methylation Dynamics in Human Induced Pluripotent Stem Cells over Time
- (2011) Koichiro Nishino et al. PLoS Genetics
- Generation of iPSCs from cultured human malignant cells
- (2010) J. E. Carette et al. BLOOD
- Generation of Induced Pluripotent Stem Cells from Human Terminally Differentiated Circulating T Cells
- (2010) Tomohisa Seki et al. Cell Stem Cell
- FGF-2 modulates Wnt signaling in undifferentiated hESC and iPS cells through activated PI3-K/GSK3β signaling
- (2010) Vanessa M.Y. Ding et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity
- (2010) Amie S. Corbin et al. JOURNAL OF CLINICAL INVESTIGATION
- Transient activation ofc-MYCexpression is critical for efficient platelet generation from human induced pluripotent stem cells
- (2010) Naoya Takayama et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial
- (2010) François-Xavier Mahon et al. LANCET ONCOLOGY
- Insights into the stem cells of chronic myeloid leukemia
- (2010) I Sloma et al. LEUKEMIA
- Regulation of somatic cell reprogramming through inducible mir-302 expression
- (2010) Shi-Lung Lin et al. NUCLEIC ACIDS RESEARCH
- A Combined Epigenetic and Non-Genetic Approach for Reprogramming Human Somatic Cells
- (2010) Jinnuo Han et al. PLoS One
- Activation of Pluripotency Genes in Human Fibroblast Cells by a Novel mRNA Based Approach
- (2010) Jordan R. Plews et al. PLoS One
- Reduction of N-Glycolylneuraminic Acid in Human Induced Pluripotent Stem Cells Generated or Cultured under Feeder- and Serum-Free Defined Conditions
- (2010) Yohei Hayashi et al. PLoS One
- Definitive proof for direct reprogramming of hematopoietic cells to pluripotency
- (2009) M. Okabe et al. BLOOD
- Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders
- (2009) Z. Ye et al. BLOOD
- Phosphoproteomic Analysis of Human Embryonic Stem Cells
- (2009) Laurence M. Brill et al. Cell Stem Cell
- Inhibition of Caspase-mediated Anoikis Is Critical for Basic Fibroblast Growth Factor-sustained Culture of Human Pluripotent Stem Cells
- (2009) Xiaofang Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells
- (2009) J. Utikal et al. JOURNAL OF CELL SCIENCE
- Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells
- (2009) Ángel Raya et al. NATURE
- Immortalization eliminates a roadblock during cellular reprogramming into iPS cells
- (2009) Jochen Utikal et al. NATURE
- The Ink4/Arf locus is a barrier for iPS cell reprogramming
- (2009) Han Li et al. NATURE
- Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells
- (2009) Elayne M Chan et al. NATURE BIOTECHNOLOGY
- Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases
- (2009) L. Ye et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Defined factors induce reprogramming of gastrointestinal cancer cells
- (2009) N. Miyoshi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors
- (2008) N. Takayama et al. BLOOD
- Disease-Specific Induced Pluripotent Stem Cells
- (2008) In-Hyun Park et al. CELL
- Evi-1 Is a Critical Regulator for Hematopoietic Stem Cells and Transformed Leukemic Cells
- (2008) Susumu Goyama et al. Cell Stem Cell
- Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2
- (2008) Danwei Huangfu et al. NATURE BIOTECHNOLOGY
- The promise of human induced pluripotent stem cells for research and therapy
- (2008) Shin-ichi Nishikawa et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Molecular Genetic Pathways as Therapeutic Targets in Acute Myeloid Leukemia
- (2008) T. Haferlach Hematology-American Society of Hematology Education Program
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search